|
FNDC8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.812200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.388200E-01 |
| Normal-vs-Stage2 |
4.997800E-01 |
| Normal-vs-Stage3 |
4.961600E-01 |
| Normal-vs-Stage4 |
5.627800E-02 |
| Stage1-vs-Stage2 |
6.563600E-01 |
| Stage1-vs-Stage3 |
4.708200E-01 |
| Stage1-vs-Stage4 |
9.821300E-03 |
| Stage2-vs-Stage3 |
2.842400E-01 |
| Stage2-vs-Stage4 |
1.176270E-02 |
| Stage3-vs-Stage4 |
4.526300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.280200E-01 |
| Normal-vs-AfricanAmerican |
8.688200E-01 |
| Normal-vs-Asian |
6.194600E-01 |
| Caucasian-vs-AfricanAmerican |
3.820400E-01 |
| Caucasian-vs-Asian |
6.577400E-01 |
| AfricanAmerican-vs-Asian |
8.067600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.107600E-01 |
| Normal-vs-Female |
2.481400E-01 |
| Male-vs-Female |
3.544000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.829800E-01 |
| Normal-vs-Extreme_Weight |
7.687400E-01 |
| Normal-vs-Obese |
2.442400E-01 |
| Normal-vs-Extreme_Obese |
6.060200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.329400E-01 |
| Normal_Weight-vs-Obese |
3.464000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.370200E-01 |
| Extreme_Weight-vs-Obese |
4.199600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.674800E-01 |
| Obese-vs-Extreme_Obese |
9.004000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.818000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.709830E-01 |
| Normal-vs-Age(61-80Yrs) |
3.456600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.996800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.495430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.085700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.513900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.401840E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.787800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.575000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.908400E-01 |
| Normal-VS-Type2 PRCC |
8.144000E-01 |
| Normal-VS-KIRP CIMP |
5.270200E-02 |
| Normal-VS-Unclassified PRCC |
9.243800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.067400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.238300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.811200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.093950E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.945000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.518000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.785200E-01 |
| Normal-vs-N1 |
2.350000E-02 |
| Normal-vs-N2 |
2.175700E-03 |
| N0-vs-N1 |
2.227800E-02 |
| N0-vs-N2 |
2.486300E-02 |
| N1-vs-N2 |
7.493800E-01 |
|
|
